Avalo Therapeutics (AVTX) Institutional Ownership $3.76 -0.16 (-3.96%) As of 10:24 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Avalo Therapeutics (NASDAQ:AVTX)CurrentInstitutional OwnershipPercentage87.06%Number ofInstitutional Buyers(last 12 months)16TotalInstitutional Inflows(last 12 months)$43.20MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$743K Get AVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AVTX Institutional Buying and Selling by Quarter Avalo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Allostery Investments LP107,141$858K1.2%+46.1%0.989% 5/16/2025 ADAR1 Capital Management LLC10,000$80K0.0%N/A0.092% 5/15/2025 Nantahala Capital Management LLC900,000$7.21M0.3%N/A8.312% 5/14/2025 Affinity Asset Advisors LLC657,154$5.26M0.5%+19.3%6.069% 5/14/2025 RWA Wealth Partners LLC312,779$2.51M0.0%N/A2.889% 2/17/2025 Velan Capital Investment Management LP109,972$817K0.7%N/A1.058% 2/17/2025 Deep Track Capital LP867,000$6.44M0.2%-10.3%8.345% 2/17/2025 BVF Inc. IL1,036,679$7.70M0.3%+7.2%9.978% 2/17/2025 Allostery Investments LP73,314$545K0.6%N/A0.706% 2/14/2025 Northern Trust Corp22,673$168K0.0%N/A0.218% Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/14/2025 Tower Research Capital LLC TRC4,130$31K0.0%+998.4%0.040% 2/13/2025 Marshall Wace LLP15,323$114K0.0%N/A0.147% 2/13/2025 Affinity Asset Advisors LLC550,765$4.09M0.5%+1,123.9%5.299% 2/13/2025 Walleye Capital LLC19,477$145K0.0%N/A0.187% 2/13/2025 Bank of Montreal Can60,000$446K0.0%N/A0.577% 2/12/2025 Geode Capital Management LLC104,853$779K0.0%+937.0%1.009% 11/15/2024 RA Capital Management L.P.967,000$9.19M0.1%N/A93.883% 11/15/2024 Ikarian Capital LLC970,359$9.22M1.2%+1,673.0%94.210% 8/27/2024 Logos Global Management LP539,079$6.72M0.5%N/A52.135% 8/15/2024 Affinity Asset Advisors LLC45,000$561K0.1%+350.0%4.352% 5/17/2024 Ikarian Capital LLC46,648$1.02M0.1%N/A4.511% 5/15/2024 Affinity Asset Advisors LLC10,000$218K0.0%N/A0.971% 5/14/2024 Natixis2,512$55K0.0%-45.4%0.244% 11/13/2023 Acadian Asset Management LLC283,306$34K0.0%N/A1.399% 8/11/2023 VR Adviser LLC1,250,000$444K0.1%+25.0%6.173% 5/16/2023 Great Point Partners LLC474,639$831K0.2%N/A3.595% 5/5/2023 Monashee Investment Management LLC60,000$105K0.0%N/A0.455% 2/15/2023 Nantahala Capital Management LLC540,667$2.73M0.2%-1.3%5.746% 11/14/2022 Armistice Capital LLC3,964,666$13.16M0.2%-91.7%42.115% 11/14/2022 Point72 Asset Management L.P.500,737$1.66M0.0%-91.7%5.319% 11/10/2022 Nantahala Capital Management LLC547,814$1.82M0.1%-91.8%5.819% 10/27/2022 Assenagon Asset Management S.A.15,646$52K0.0%N/A0.166% 8/15/2022 Nantahala Capital Management LLC6,710,327$3.36M0.2%-2.0%71.280% 8/15/2022 Opaleye Management Inc.450,000$225K0.1%-69.1%4.780% 5/12/2022 Integral Health Asset Management LLC700,000$507K0.1%-56.9%0.621% 5/3/2022Leo Brokerage LLC62,629$45K0.0%N/A0.056% 4/25/2022 Assenagon Asset Management S.A.42,338$31K0.0%-92.7%0.038% 2/15/2022 Stonepine Capital Management LLC1,510,095$2.57M1.2%+77.7%1.344% 2/15/2022 LGL Partners LLC28,850$49K0.0%N/A0.026% 2/14/2022 Freestone Capital Holdings LLC20,000$34K0.0%N/A0.018% Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos2/14/2022 Soleus Capital Management L.P.770,000$1.31M0.1%N/A0.686% 2/8/2022 Northern Trust Corp533,578$907K0.0%+3.1%0.475% 2/1/2022 Assenagon Asset Management S.A.582,718$991K0.0%-33.7%0.519% 1/24/2022Strs Ohio38,400$65K0.0%-40.2%0.034% 1/20/2022Minot Wealth Management LLC34,645$59K0.0%-66.5%0.031% 12/29/2021 Hudson Bay Capital Management LP197,133$430K0.0%N/A0.176% 11/16/2021 Opaleye Management Inc.1,459,400$3.18M0.6%N/A1.299% 11/16/2021 Squarepoint Ops LLC18,657$41K0.0%N/A0.017% 11/16/2021 Two Sigma Advisers LP801,300$1.75M0.0%N/A0.713% 11/16/2021 Two Sigma Investments LP732,931$1.60M0.0%N/A0.653% 11/16/2021 Laurion Capital Management LP330,444$720K0.0%N/A0.294% 11/15/2021 Point72 Asset Management L.P.6,008,850$13.10M0.1%N/A5.350% 11/15/2021 Atom Investors LP27,507$60K0.0%N/A0.024% 11/15/2021 Voya Investment Management LLC21,854$48K0.0%N/A0.019% 11/15/2021 Caas Capital Management LP11,812$26K0.0%N/A0.011% 11/12/2021 Aristides Capital LLC48,953$107K0.0%N/A0.044% 11/12/2021 Stonepine Capital Management LLC850,000$1.85M0.8%N/A0.770% 11/12/2021 Geode Capital Management LLC1,242,382$2.71M0.0%N/A1.126% 11/12/2021 Integral Health Asset Management LLC1,625,000$3.54M1.0%N/A1.473% 11/10/2021 Goldman Sachs Group Inc.672,664$1.47M0.0%N/A0.610% 11/10/2021 Creative Planning14,814$32K0.0%N/A0.013% 11/10/2021 Alliancebernstein L.P.19,100$42K0.0%N/A0.017% 11/9/2021BlackRock Inc.3,716,943$8.10M0.0%N/A3.369% 11/9/2021 Monashee Investment Management LLC270,000$589K0.1%N/A0.245% 11/8/2021 Meeder Asset Management Inc.19,260$43K0.0%N/A0.017% 11/4/2021Asymmetry Capital Management L.P.534,621$1.17M0.7%N/A0.485% 11/4/2021 Deutsche Bank AG31,794$69K0.0%N/A0.029% 11/2/2021 Cambridge Investment Research Advisors Inc.12,164$27K0.0%N/A0.011% 11/2/2021 New York State Common Retirement Fund22,214$48K0.0%N/A0.020% 11/2/2021 Victory Capital Management Inc.15,788$34K0.0%N/A0.014% 11/1/2021 SG Americas Securities LLC18,596$41K0.0%N/A0.017% 10/29/2021 Commonwealth Equity Services LLC52,000$113K0.0%N/A0.047% 10/25/2021Minot Wealth Management LLC103,410$225K0.0%N/A0.094% 10/22/2021Strs Ohio64,200$139K0.0%N/A0.058% 10/19/2021 Assenagon Asset Management S.A.879,334$1.92M0.0%N/A0.797% 10/19/2021 Tamar Securities LLC23,084$50K0.0%N/A0.021% (Data available from 1/1/2016 forward) AVTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AVTX shares? During the previous two years, 20 institutional investors and hedge funds held shares of Avalo Therapeutics. The most heavily invested institutionals were Ikarian Capital LLC ($9.22M), RA Capital Management L.P. ($9.19M), BVF Inc. IL ($7.70M), Nantahala Capital Management LLC ($7.21M), Logos Global Management LP ($6.72M), Deep Track Capital LP ($6.44M), and Affinity Asset Advisors LLC ($5.26M).Learn more on AVTX's institutional investors. What percentage of Avalo Therapeutics stock is owned by institutional investors? 87.06% of Avalo Therapeutics stock is owned by institutional investors. Learn more on AVTX's institutional investor holdings. Which institutional investors have been buying Avalo Therapeutics stock? Of the 18 institutional investors that purchased Avalo Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($967K), Ikarian Capital LLC ($962.28K), Nantahala Capital Management LLC ($900K), Affinity Asset Advisors LLC ($657.15K), Logos Global Management LP ($539.08K), RWA Wealth Partners LLC ($312.78K), and Acadian Asset Management LLC ($283.31K). How much institutional buying is happening at Avalo Therapeutics? Institutional investors have bought a total of 5,384,356 shares in the last 24 months. This purchase volume represents approximately $73.95M in transactions. Which Avalo Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Avalo Therapeutics stock in the last 24 months: Deep Track Capital LP ($100K), and Natixis ($2.09K). How much institutional selling is happening at Avalo Therapeutics? Institutional investors have sold a total of 102,092 shares in the last 24 months. This volume of shares sold represents approximately $788.50K in transactions. Related Companies Tiziana Life Sciences Institutional Ownership Eledon Pharmaceuticals Institutional Ownership CytomX Therapeutics Institutional Ownership Esperion Therapeutics Institutional Ownership LifeVantage Institutional Ownership Inventiva Institutional Ownership TuHURA Biosciences Institutional Ownership SELLAS Life Sciences Group Institutional Ownership Cybin Institutional Ownership Alpha Cognition Institutional Ownership This page (NASDAQ:AVTX) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVTX Stock Free AVTX Stock Alerts